- Title
- Randomized, dose-escalation study of the p38 alpha MAPK inhibitor SCIO-469 in patients with myelodysplastic syndrome
- Creators
- L. Sokol - University of South FloridaL. Cripe - Indiana University BloomingtonH. Kantarjian - The University of Texas MD Anderson Cancer CenterM. A. Sekeres - Cleveland ClinicS. Parmar - College Station Medical CenterP. Greenberg - Stanford UniversityS. L. Goldberg - College Station Medical CenterV. Bhushan - The University of Texas Southwestern Medical CenterJ. Shammo - Rush UniversityR. Hohl - University of IowaA. Verma - Yeshiva UniversityG. Garcia-Manero - The University of Texas MD Anderson Cancer CenterY-P Li - Scios Inc.A. Lowe - Scios Inc.J. Zhu - Scios Inc.A. F. List - University of South Florida
- Publication Details
- Leukemia, Vol.27(4), pp.977-980
- Publisher
- Springer Nature
- Number of pages
- 5
- Grant note
- P30 CA016672 / NCI NIH HHS; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI) P30CA016672 / NATIONAL CANCER INSTITUTE; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)
- Academic Unit
- Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
- Language
- English
- Resource Type
- Journal article
- PMID
- 23032694
- Record Identifier
- 991031757893602976
Journal article
Randomized, dose-escalation study of the p38 alpha MAPK inhibitor SCIO-469 in patients with myelodysplastic syndrome
Leukemia, Vol.27(4), pp.977-980
2013-04-01
PMID: 23032694
Metrics
1 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Industry collaboration
- Domestic collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.103 Blood Disorders
- 1.103.155 Acute Myeloid Leukemia
- Web Of Science research areas
- Hematology
- Oncology
- ESI research areas
- Clinical Medicine
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites